Quantification of type II procollagen splice forms using alternative transcript-qPCR (AT-qPCR).

Area of Science:

• Molecular Biology
• Developmental Biology
• Genetics

Background:

• Chondrogenic differentiation initiates with procollagen type II (Col2a1) gene expression.
• Col2a1 exon 2 encodes a von Willebrand factor C-like domain, crucial for IIA and IID splice forms in chondroprogenitors.
• Further differentiation shifts expression to the shorter, exon 2-lacking IIB splice form.

Purpose of the Study:

• To develop and validate a precise method for quantifying alternatively spliced Col2a1 mRNA.
• To accurately measure Col2a1 splice form expression during chondrocyte differentiation in vitro and in vivo.
• To address inaccuracies associated with traditional semi-quantitative PCR for alternative splicing analysis.

Main Methods:

• Development of the TaqMan®-based Alternative Transcript-qPCR (AT-qPCR) assay.
• Utilized a multiple-amplicon standard (MAS) plasmid for standard curve-based quantification.
• Validated the assay in differentiating ATDC5 cells and wild-type mouse cartilage (embryonic to postnatal).

Main Results:

• The AT-qPCR assay accurately quantified Col2a1 splice forms, overcoming PCR amplification biases.
• In vivo mouse cartilage showed the expected switch from IIA to IIB splice forms.
• ATDC5 cell cultures predominantly expressed IIA and IID forms, suggesting incomplete differentiation.

Conclusions:

• The AT-qPCR assay provides a valid and accurate method for measuring procollagen type II splice forms.
• This technique enables better monitoring of chondrocyte differentiation in various model systems.
• The AT-qPCR assay is adaptable for quantifying alternative splice forms of other genes and for high-throughput screening.